238 related articles for article (PubMed ID: 16568081)
1. Bcl-2 is a key regulator for the retinoic acid-induced apoptotic cell death in neuroblastoma.
Niizuma H; Nakamura Y; Ozaki T; Nakanishi H; Ohira M; Isogai E; Kageyama H; Imaizumi M; Nakagawara A
Oncogene; 2006 Aug; 25(36):5046-55. PubMed ID: 16568081
[TBL] [Abstract][Full Text] [Related]
2. All-trans retinoic acid arrests neuroblastoma cells in a dormant state. Subsequent nerve growth factor/brain-derived neurotrophic factor treatment adds modest benefit.
Cernaianu G; Brandmaier P; Scholz G; Ackermann OP; Alt R; Rothe K; Cross M; Witzigmann H; Tröbs RB
J Pediatr Surg; 2008 Jul; 43(7):1284-94. PubMed ID: 18639684
[TBL] [Abstract][Full Text] [Related]
3. Differentiation of neuroblastoma enhances Bcl-2 expression and induces alterations of apoptosis and drug resistance.
Lasorella A; Iavarone A; Israel MA
Cancer Res; 1995 Oct; 55(20):4711-6. PubMed ID: 7553653
[TBL] [Abstract][Full Text] [Related]
4. Alpha-tocopheryl succinate selectively induces apoptosis in neuroblastoma cells: potential therapy of malignancies of the nervous system?
Swettenham E; Witting PK; Salvatore BA; Neuzil J
J Neurochem; 2005 Sep; 94(5):1448-56. PubMed ID: 16001965
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of N-(4-hydroxyphenyl)retinamide and retinoic acid on neuroblastoma cells: apoptosis versus differentiation.
Ponzoni M; Bocca P; Chiesa V; Decensi A; Pistoia V; Raffaghello L; Rozzo C; Montaldo PG
Cancer Res; 1995 Feb; 55(4):853-61. PubMed ID: 7850799
[TBL] [Abstract][Full Text] [Related]
6. Retinoid-induced apoptosis in HL-60 cells is associated with nucleolin down-regulation and destabilization of Bcl-2 mRNA.
Otake Y; Sengupta TK; Bandyopadhyay S; Spicer EK; Fernandes DJ
Mol Pharmacol; 2005 Jan; 67(1):319-26. PubMed ID: 15492114
[TBL] [Abstract][Full Text] [Related]
7. Expression profiles of p53, p21, bax and bcl-2 proteins in all-trans-retinoic acid treated primary and metastatic melanoma cells.
Zhang H; Rosdahl I
Int J Oncol; 2004 Aug; 25(2):303-8. PubMed ID: 15254726
[TBL] [Abstract][Full Text] [Related]
8. BMP-6 and retinoic acid synergistically differentiate the IMR-32 human neuroblastoma cells.
Sumantran VN; Brederlau A; Funa K
Anticancer Res; 2003; 23(2B):1297-303. PubMed ID: 12820386
[TBL] [Abstract][Full Text] [Related]
9. Programmed cell death-4 tumor suppressor protein contributes to retinoic acid-induced terminal granulocytic differentiation of human myeloid leukemia cells.
Ozpolat B; Akar U; Steiner M; Zorrilla-Calancha I; Tirado-Gomez M; Colburn N; Danilenko M; Kornblau S; Berestein GL
Mol Cancer Res; 2007 Jan; 5(1):95-108. PubMed ID: 17259349
[TBL] [Abstract][Full Text] [Related]
10. An association between mitochondrial function and all-trans retinoic acid-induced apoptosis in acute myeloblastic leukaemia cells.
Zheng A; Mäntymaa P; Säily M; Siitonen T; Savolainen ER; Koistinen P
Br J Haematol; 1999 Apr; 105(1):215-24. PubMed ID: 10233386
[TBL] [Abstract][Full Text] [Related]
11. Proapoptotic compound ARC targets Akt and N-myc in neuroblastoma cells.
Radhakrishnan SK; Halasi M; Bhat UG; Kurmasheva RT; Houghton PJ; Gartel AL
Oncogene; 2008 Jan; 27(5):694-9. PubMed ID: 17724478
[TBL] [Abstract][Full Text] [Related]
12. Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: Relationship to Bcl-2 family and caspase activation.
Hamaï A; Richon C; Meslin F; Faure F; Kauffmann A; Lecluse Y; Jalil A; Larue L; Avril MF; Chouaib S; Mehrpour M
Oncogene; 2006 Dec; 25(58):7618-34. PubMed ID: 16983347
[TBL] [Abstract][Full Text] [Related]
13. All-trans retinoic acid can intensify the growth inhibition and differentiation induction effect of rosiglitazone on multiple myeloma cells.
Huang H; Wu D; Fu J; Chen G; Chang W; Chow HC; Leung AY; Liang R
Eur J Haematol; 2009 Sep; 83(3):191-202. PubMed ID: 19467017
[TBL] [Abstract][Full Text] [Related]
14. High expression of Survivin, mapped to 17q25, is significantly associated with poor prognostic factors and promotes cell survival in human neuroblastoma.
Islam A; Kageyama H; Takada N; Kawamoto T; Takayasu H; Isogai E; Ohira M; Hashizume K; Kobayashi H; Kaneko Y; Nakagawara A
Oncogene; 2000 Feb; 19(5):617-23. PubMed ID: 10698506
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of staurosporine and retinoic acid on the vulnerability of the SH-SY5Y neuroblastoma cells: involvement of bcl-2 and p53 proteins.
Tieu K; Zuo DM; Yu PH
J Neurosci Res; 1999 Nov; 58(3):426-35. PubMed ID: 10518116
[TBL] [Abstract][Full Text] [Related]
16. [Apoptosis in esophageal cancer cells induced by all-trans retinoic acid].
Lu TY; Fan QX; Wang LX; Wang RL; Zhao PR; Lu SX
Zhonghua Zhong Liu Za Zhi; 2007 Nov; 29(11):822-5. PubMed ID: 18396638
[TBL] [Abstract][Full Text] [Related]
17. Thrombospondin-1 (TSP-1) and TSP-1-derived heparin-binding peptides induce promyelocytic leukemia cell differentiation and apoptosis.
Bruel A; Touhami-Carrier M; Thomaidis A; Legrand C
Anticancer Res; 2005; 25(2A):757-64. PubMed ID: 15868907
[TBL] [Abstract][Full Text] [Related]
18. Bcl-2 expression in neuroblastoma is differentially regulated by differentiation inducers.
Kim CJ; Kim HO; Choe YJ; Lee YA; Kim CW
Anticancer Res; 1995; 15(5B):1997-2000. PubMed ID: 8572591
[TBL] [Abstract][Full Text] [Related]
19. Tauroursodeoxycholic acid modulates p53-mediated apoptosis in Alzheimer's disease mutant neuroblastoma cells.
Ramalho RM; Borralho PM; Castro RE; Solá S; Steer CJ; Rodrigues CM
J Neurochem; 2006 Sep; 98(5):1610-8. PubMed ID: 16923170
[TBL] [Abstract][Full Text] [Related]
20. Regulation of Bcl-2 oncoprotein levels with differentiation of human neuroblastoma cells.
Hanada M; Krajewski S; Tanaka S; Cazals-Hatem D; Spengler BA; Ross RA; Biedler JL; Reed JC
Cancer Res; 1993 Oct; 53(20):4978-86. PubMed ID: 8402688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]